Aktie A2P5NK AVIDITY BIOSCIENCES, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Avidity Biosciences, Inc.

Aktien

A2P5NK

US05370A1088

RNA

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:00:00 21.06.2024 		% 5 Tage % 1. Jan.
39 USD +3,70 % Intraday Chart für Avidity Biosciences, Inc. -1,61 % +330,94 %
21.06. Avidity Biosciences Insider verkaufte Aktien im Wert von $1.255.040, laut einer aktuellen SEC Einreichung MT
14.06. AVIDITY BIOSCIENCES, INC. : Bewertung von Wells Fargo Securities zum Kaufen erhalten ZM

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Avidity Biosciences : June 2024 Corporate Presentation
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Avidity Biosciences Insider Sold Shares Worth $1,255,040, According to a Recent SEC Filing
Avidity Biosciences Partners with the FSHD Society to Raise Awareness of Facioscapulohumeral Muscular Dystrophy on World FSHD Day
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters Option to Purchase Additional Shares
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
Avidity Biosciences to Participate in Upcoming Investor Conference
Avidity Biosciences Prices $400.9 Million Offering of Shares
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE Trial Demonstrating Greater Than 50 Percent Reduction in DUX4 Regulated Genes
Avidity Biosciences Plans $300 Million Common Stock Offering
Sector Update: Health Care Stocks Ease Late Afternoon
Avidity Biosciences, Inc. Announces Proposed Public Offering of Common Stock
Sector Update: Health Care Stocks Softer Wednesday Afternoon
Avidity Biosciences Shares Jump as Muscle Disease Therapy Shows Promising Early Results
Sector Update: Health Care
Top Midday Gainers
Avidity Biosciences's Muscle Disease Therapy Shows Promising Early Results -- Shares Surge Pre-Bell
Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE™ Trial Demonstrating Greater Than 50 Percent Reduction in DUX4 Regulated Genes and Trends of Functional Improvement in People Living with Facioscapulohumeral Muscular Dystrophy
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2P5NK Aktie
  4. Nachrichten Avidity Biosciences, Inc.
  5. Andere Sprachen